arrow
K

Kalil G. Abdullah

northwell health
H指数:38
被引数:4,613

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reply to “Ascertainment of overall survival and the proposed molecular grading tier in IDH-mutant astrocytoma”

回复“IDH突变型星形细胞瘤的整体生存评估及提出的分子分级分层”

2026-09-030
PRE
Vorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant glioma

Vorasanib在IDH突变胶质瘤的基因工程小鼠模型中改善了对后续放化疗的反应

2026-08-050
PRE
Memory circuit dosimetry in patients with brain metastases treated with Sparing Memory with Advanced Radiosurgery Targeting (SMART) technique

脑转移瘤患者中采用Sparing Memory with Advanced Radiosurgery Targeting (SMART) 技术治疗的记忆电路剂量测定

2026-08-010
OAAI
Validation of proposed cIMPACT-NOW update 12 molecular grading criteria for IDH-mutant astrocytoma

验证针对IDH突变型星形细胞瘤提出的cIMPACT-NOW更新12分子分级标准

2026-07-220
OAAI
A transcriptional biosensor reveals mechanisms of α-ketoglutarate signaling to chromatin

转录生物传感器揭示了α-酮戊二酸向染色质的信号传导机制

Science
IF45.8
2026-07-160
PRE
Expanding the molecular grading criteria in IDH-mutant astrocytoma

扩展IDH突变型星形细胞瘤的分子分级标准

2026-05-010
PRE
Nitrogen metabolism profiling reveals cell state-specific pyrimidine synthesis pathway choice

氮代谢组分析揭示了细胞状态特异性的嘧啶合成通路选择

2026-04-290
OAAI
Preclinical and clinical assessment of chemoradiation after mutant IDH inhibitor treatment in IDH-mutant glioma

IDH突变抑制剂治疗后IDH突变胶质瘤的化学放射治疗预临床与临床评估

2025-11-010
OAAI
Cell-intrinsic pyrimidine synthesis pathway choice in human brain and glioma

人脑和胶质瘤中细胞内源性嘧啶合成通路的选择

2025-11-010
OAAI
A Targetable Metabolic Signal Drives Neuronal Hyperexcitability and Glioma Aggressiveness

一种可靶向的代谢信号驱动神经元过度兴奋性和胶质瘤侵袭性

2025-11-010
OAAI